Comment on: Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children

J Antimicrob Chemother. 2010 Apr;65(4):808-9; author reply 809-10. doi: 10.1093/jac/dkp489. Epub 2010 Jan 19.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / pharmacokinetics*
  • Anti-HIV Agents / therapeutic use*
  • Child
  • Child, Preschool
  • HIV Infections / drug therapy*
  • Humans
  • Lopinavir
  • Pyrimidinones / administration & dosage
  • Pyrimidinones / pharmacokinetics*
  • Pyrimidinones / therapeutic use*
  • Ritonavir / administration & dosage
  • Ritonavir / pharmacokinetics*
  • Ritonavir / therapeutic use*
  • Treatment Outcome

Substances

  • Anti-HIV Agents
  • Pyrimidinones
  • Lopinavir
  • Ritonavir